Table 6.
An overview of the literature on the effect of conversion from sleeve gastrectomy to Roux-en-Y gastric bypass on gastroesophageal reflux disease. ACM = acid suppression medication, GERD = gastroesophageal reflux disease, RYGB = Roux-en-Y gastric bypass, N/R = not reported.
| The Effect of Conversion from Sleeve Gastrectomy to Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease | |||||
|---|---|---|---|---|---|
| Author | Year | Journal | Article Type | Conversion Rate to RYGB for GERD (%) | Effect on GERD Symptoms and Use of Acid Suppression Medications |
| Langer et al. [136] | 2010 | Obesity Surgery | Retrospective review | 11 | 100% of patients with severe reflux discontinued ACM |
| Salminen et al. [137] | 2018 | JAMA | Randomized clinical trial | 6 | N/R |
| Parmar et al. [138] | 2017 | Obesity Surgery | Prospective study | 45 | 100% of patients reported improvement in GERD symptoms 80% of patients were able to discontinue ACM |
| Abdemur et al. [139] |
2016 | Surgery for Obesity and Related Diseases | Retrospective review | 0.8 | 66% of patients had complete resolution of GERD symptoms |
| Hendricks et al. [140] | 2016 | Surgery for Obesity and Related Diseases | Retrospective review, comparative study | 10.5 | 75% of patients had complete resolution of GERD symptoms 25% of patients had partial resolution |
| Gautier et al. [141] | 2013 | Obesity Surgery | Retrospective review | 33.3 | 100% of patients discontinued ACM No recurrence of GERD was noted |
| Strauss et al. [142] | 2023 | Surgical Endoscopy | Retrospective review | 72.2 | 80.2% of patients had improvement in GERD symptoms 19.4% of patients were able to discontinue ACM |
| Felsenreich et al. [144] | 2022 | Obesity Surgery | Retrospective review | 34.2 | 29.9% of patients reported GERD symptoms following conversion |
| Peng et al. [145] | 2020 | Surgery for Obesity and Related Diseases | Systematic Review and Meta-analysis | N/R | 57.1–100% had remission or improvement in GERD symptoms |